Supply Chain | April 17, 2026
Syntegon reports record FY25 Results; revenue rises 10% to €1.75 billion
The company allocated €56 million to research and development for next-generation line solutions
The company allocated €56 million to research and development for next-generation line solutions
Collaboration integrates AJICAP™ technology with global manufacturing capabilities to streamline antibody-drug conjugate pipelines
Muted movement reflects consolidation phase as investors await earnings triggers
New purpose-built AI model targets faster R&D cycles and deeper scientific insights across life sciences
One Health-based surveillance model to focus on bird sanctuaries and high-risk human populations
ICMR-led consultation calls for stricter HFSS regulations, nutrition literacy, and healthier food environments
Zero-observation outcomes strengthen global credibility and accelerate CDMO ambitions
American College of Cardiology and Korean Society of Cardiology convene global experts to address rising cardiometabolic burden
4th World Homoeopathy Summit at Palace of Westminster and University of Oxford spotlights integrative healthcare and global collaboration
The company reported net revenue of SEK 13.5 million for the full year 2025
Subscribe To Our Newsletter & Stay Updated
